[1]
2010. Effect of Hydroxymethylglutaryl-CoA Reductase Inhibitors on Low-density Lipoprotein Cholesterol, Interleukin-6, and High-Sensitivity C-Reactive Protein in End-stage Renal Disease. Iranian Journal of Kidney Diseases. 5, 1 (Dec. 2010), 29–33.